| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CELGENE CORP | 125,000 | 12,329,000 | 5.02% | ||
| 2 | ZIMMER BIOMET HLDGS INC | 100,000 | 12,038,000 | 4.90% | ||
| 3 | GILEAD SCIENCES INC | 135,000 | 11,262,000 | 4.58% | ||
| 4 | SHIRE PLC | 60,000 | 11,045,000 | 4.49% | ||
| 5 | ANTHEM INC | 70,000 | 9,194,000 | 3.74% | ||
| 6 | ONCOMED PHARMACEUTICALS INC | 632,200 | 7,782,000 | 3.17% | ||
| 7 | MERCK & CO INC | 125,000 | 7,201,000 | 2.93% | ||
| 8 | PFIZER INC | 200,000 | 7,042,000 | 2.86% | ||
| 9 | ULTRAGENYX PHARMACEUTICAL INC COM | 140,000 | 6,847,000 | 2.79% | ||
| 10 | BAXTER INTL INC | 135,000 | 6,105,000 | 2.48% | ||
| 11 | NUVASIVE INC COM | 100,000 | 5,972,000 | 2.43% | ||
| 12 | ALEXION PHARMACEUTIC | 50,000 | 5,838,000 | 2.37% | ||
| 13 | ALEXION PHARMACEUTICALS INC | 50,000 | 5,838,000 | 2.37% | Call | |
| 14 | BIOGEN INC | 22,500 | 5,441,000 | 2.21% | ||
| 15 | AMGEN INC | 35,000 | 5,325,000 | 2.17% | ||
| 16 | GLOBAL BLOOD THERAPEUTICS IN COM | 300,000 | 4,977,000 | 2.02% | ||
| 17 | MEDICINES CO | 140,000 | 4,708,000 | 1.92% | Call | |
| 18 | SUPERNUS PHARMACEUTICALS INC COM | 225,000 | 4,583,000 | 1.86% | ||
| 19 | DERMIRA INC | 150,000 | 4,388,000 | 1.78% | ||
| 20 | TENET HEALTHCARE CORP | 150,000 | 4,146,000 | 1.69% | ||
| 21 | GLAUKOS CORP | 135,000 | 3,937,000 | 1.60% | ||
| 22 | ELI LILLY & CO | 50,000 | 3,908,000 | 1.59% | Put | |
| 23 | HCA HOLDINGS INC | 50,000 | 3,851,000 | 1.57% | ||
| 24 | MAZOR ROBOTICS LTD | 200,000 | 3,596,000 | 1.46% | ||
| 25 | ILLUMINA INC | 25,000 | 3,510,000 | 1.43% | ||
| 26 | CIGNA CORPORATION | 25,000 | 3,200,000 | 1.30% | Call | |
| 27 | ALLSCRIPTS HEALTHCARE | 250,000 | 3,175,000 | 1.29% | ||
| 28 | ABBVIE INC | 50,000 | 3,096,000 | 1.26% | Call | |
| 29 | SPARK THERAPEUTICS INC | 60,000 | 3,068,000 | 1.25% | ||
| 30 | EXELIXIS INC | 350,000 | 2,734,000 | 1.11% | ||
| 31 | AERIE PHARMACEUTICALS INC | 150,000 | 2,640,000 | 1.07% | ||
| 32 | HEALTHWAYS INC | 225,000 | 2,599,000 | 1.06% | ||
| 33 | KITE PHARMA INCORPORATED | 50,000 | 2,500,000 | 1.02% | ||
| 34 | BOSTON SCIENTIFIC CORP | 100,000 | 2,337,000 | 0.95% | ||
| 35 | K2M GROUP HLDGS INC COM | 140,000 | 2,173,000 | 0.88% | ||
| 36 | ACCELERATE DIAGNOSTICS INC | 150,000 | 2,158,000 | 0.88% | ||
| 37 | SPECTRANETICS CORP | 110,000 | 2,058,000 | 0.84% | ||
| 38 | EPIZYME INC COM | 200,000 | 2,048,000 | 0.83% | ||
| 39 | MACROGENICS INC | 75,000 | 2,024,000 | 0.82% | ||
| 40 | MEDICINES CO | 60,000 | 2,018,000 | 0.82% | ||
| 41 | Intersect ENT Inc | 150,000 | 1,940,000 | 0.79% | ||
| 42 | BIOSCRIP INC | 750,000 | 1,913,000 | 0.78% | ||
| 43 | RADIUS HEALTH INC | 50,000 | 1,838,000 | 0.75% | Put | |
| 44 | RADIUS HEALTH | 50,000 | 1,838,000 | 0.75% | ||
| 45 | UNITEDHEALTH GROUP INC | 12,500 | 1,765,000 | 0.72% | ||
| 46 | ACCELERON PHARMA | 50,000 | 1,699,000 | 0.69% | ||
| 47 | ADAPTIMMUNE THERAPEUTICS PLC | 200,000 | 1,630,000 | 0.66% | ||
| 48 | WELLCARE HEALTH PLANS INC | 15,000 | 1,609,000 | 0.65% | Put | |
| 49 | PHARMERICA CORP | 65,000 | 1,603,000 | 0.65% | ||
| 50 | MERUS N V | 200,000 | 1,598,000 | 0.65% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001597549-16-000021, filed 2016.11.04).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
